Chronic lymphocytic leukaemia (CLL) is the most common leukaemia in the Western world.
It is characterized by the monoclonal expansion of small mature-looking B cells that …

Chronic lymphocytic leukemia (CLL), the most frequent leukemia in the western world,
cannot be cured with current treatment strategies. The central clinical problem of CLL is to …

Chronic lymphocytic leukemia of the B‐cell type CLL) is the most frequent leukemia in the
Western hemisphere. Recent advances in the understanding of the pathogenesis of this …

The monoclonal population of B cells in chronic lymphocytic leukemia (CLL) express CD19,
CD5, and CD23 and have reduced levels of membrane immunoglobulins (Igs), a phenotype …

With this book we have endeavored to develop a comprehensive and up-to-date picture of
chronic lymphocytic leukemia. The authors represented herein are some of the leading …

David Galton pioneered our understanding of chronic lymphocytic leukemia (CLL) by
recognising the remarkable clinical heterogeneity of the disease reflected in the pattern of …

Chronic lymphocytic leukemia (CLL) is characterized by small, resting, long lived B cells that
co-express on the surface (s) faint levels of immunoglobulins (Ig) with the CD5 molecule and …

B cell chronic lymphocytic leukaemia (CLL) is the most common adult leukaemia that follows
an extremely variable clinical course. Several important prognostic parameters defining …

Chronic lymphocytic leukemia (CLL) follows an extremely variable course with survival
ranging from months to decades. Recently, there has been major progress in the …

B-chronic lymphocytic leukemia (CLL) is the most common type of leukemia in western
countries. Research during the last two decades has contributed to better understanding of …